AE
MIST icon

AMH Equity’s Milestone Pharmaceuticals MIST Stock Holding History

AMH Equity’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$463K Buy
+231,671
New +$407K 0.58% 45

Other funds holding MIST

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

AMH Equity's MIST Position: Q3 2025 in Review

AMH Equity opened a new position in Milestone Pharmaceuticals (MIST) in Q3 2025: 231,671 shares worth $463K. The stake represents 0.58% of the portfolio and ranks #45 among its holdings.

61 funds tracked by Wall St. Rank hold MIST as of Q3 2025.

  • AMH Equity held 231,671 shares of Milestone Pharmaceuticals worth $463K as of Q3 2025.
  • Milestone Pharmaceuticals was a new AMH Equity position in Q3 2025.
  • Milestone Pharmaceuticals made up 0.58% of AMH Equity's portfolio in Q3 2025, its #45 holding.
  • 61 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.